47264 Search Results


anti spc24  (Novus Biologicals)
92
Novus Biologicals anti spc24
Clinicopathological parameters and <t> SPC24 </t> expression according to the TCGA database.
Anti Spc24, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti spc24/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
anti spc24 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
novartis wo 2009/47264  (Novartis)
90
Novartis novartis wo 2009/47264
Clinicopathological parameters and <t> SPC24 </t> expression according to the TCGA database.
Novartis Wo 2009/47264, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/novartis wo 2009/47264/product/Novartis
Average 90 stars, based on 1 article reviews
novartis wo 2009/47264 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Clinicopathological parameters and SPC24 expression according to the TCGA database.

Journal: BioMed Research International

Article Title: Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer

doi: 10.1155/2023/1733100

Figure Lengend Snippet: Clinicopathological parameters and SPC24 expression according to the TCGA database.

Article Snippet: The primary antibodies were as follows: anti-HOXB7 (Novus, NBP2-14098, 1 : 50), anti-SPC24 (Novus, NBP2-47264, 1 : 50), anti-SELENBP1 (Novus, NBP1-54805, 1 : 50), and anti-CDK1 (Abcam, ab133327, 1 : 50).

Techniques: Expressing

Univariate and multivariate Cox regression analysis of SPC24 clinical pathologic features according to the TCGA database.

Journal: BioMed Research International

Article Title: Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer

doi: 10.1155/2023/1733100

Figure Lengend Snippet: Univariate and multivariate Cox regression analysis of SPC24 clinical pathologic features according to the TCGA database.

Article Snippet: The primary antibodies were as follows: anti-HOXB7 (Novus, NBP2-14098, 1 : 50), anti-SPC24 (Novus, NBP2-47264, 1 : 50), anti-SELENBP1 (Novus, NBP1-54805, 1 : 50), and anti-CDK1 (Abcam, ab133327, 1 : 50).

Techniques: Expressing

Validation of hub gene. The correlation between the expression levels of hub genes and the survival of LSCC patients. (a) HOXB7, (b) SPC24, and (c) SELENBP1. (d) Heatmap showing the changing process between down- and upregulation of 3 hub genes. Each column represents a sample and each row represents a gene. The validation of hub gene expression in GSE127165. (e) HOXB7, (f) SPC24, and (g) CDK1.

Journal: BioMed Research International

Article Title: Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer

doi: 10.1155/2023/1733100

Figure Lengend Snippet: Validation of hub gene. The correlation between the expression levels of hub genes and the survival of LSCC patients. (a) HOXB7, (b) SPC24, and (c) SELENBP1. (d) Heatmap showing the changing process between down- and upregulation of 3 hub genes. Each column represents a sample and each row represents a gene. The validation of hub gene expression in GSE127165. (e) HOXB7, (f) SPC24, and (g) CDK1.

Article Snippet: The primary antibodies were as follows: anti-HOXB7 (Novus, NBP2-14098, 1 : 50), anti-SPC24 (Novus, NBP2-47264, 1 : 50), anti-SELENBP1 (Novus, NBP1-54805, 1 : 50), and anti-CDK1 (Abcam, ab133327, 1 : 50).

Techniques: Expressing

Coexpression network of four hub genes. (a) Visualized coexpression of four hub genes. Visualization of correlation analysis of gene expression values of the four hub genes. (b) SPC24 vs. CDK1. (c) HOXB7 vs. CDK1. (d) HOXB7 vs. SPC24. (e) SELENBP1 vs. CDK1. (f) SELENBP1 vs. SPC24. (g) SELENBP1 vs. HOXB7. P < 0.05 considered that there is a significant correlation between the expression of the two genes.

Journal: BioMed Research International

Article Title: Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer

doi: 10.1155/2023/1733100

Figure Lengend Snippet: Coexpression network of four hub genes. (a) Visualized coexpression of four hub genes. Visualization of correlation analysis of gene expression values of the four hub genes. (b) SPC24 vs. CDK1. (c) HOXB7 vs. CDK1. (d) HOXB7 vs. SPC24. (e) SELENBP1 vs. CDK1. (f) SELENBP1 vs. SPC24. (g) SELENBP1 vs. HOXB7. P < 0.05 considered that there is a significant correlation between the expression of the two genes.

Article Snippet: The primary antibodies were as follows: anti-HOXB7 (Novus, NBP2-14098, 1 : 50), anti-SPC24 (Novus, NBP2-47264, 1 : 50), anti-SELENBP1 (Novus, NBP1-54805, 1 : 50), and anti-CDK1 (Abcam, ab133327, 1 : 50).

Techniques: Expressing

Differences in protein expression of four hub genes. (a) Western blot analysis was performed to quantify the protein expression of SELENBP1, HOXB7, SPC24, and CDK1 in the LSCC and NT groups. (b) Protein levels were normalized to β -actin. Quantification of protein levels such as those in (a) is shown in (b). (c) Representative immunostaining of SELENBP1, SPC24, HOXB7, and CDK1 in LSCC and NT groups. All magnification 400x. Each data was presented as mean ± SEM ( n ≥ 6/group). ∗∗∗∗ P < 0.0001 versus the NT group.

Journal: BioMed Research International

Article Title: Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer

doi: 10.1155/2023/1733100

Figure Lengend Snippet: Differences in protein expression of four hub genes. (a) Western blot analysis was performed to quantify the protein expression of SELENBP1, HOXB7, SPC24, and CDK1 in the LSCC and NT groups. (b) Protein levels were normalized to β -actin. Quantification of protein levels such as those in (a) is shown in (b). (c) Representative immunostaining of SELENBP1, SPC24, HOXB7, and CDK1 in LSCC and NT groups. All magnification 400x. Each data was presented as mean ± SEM ( n ≥ 6/group). ∗∗∗∗ P < 0.0001 versus the NT group.

Article Snippet: The primary antibodies were as follows: anti-HOXB7 (Novus, NBP2-14098, 1 : 50), anti-SPC24 (Novus, NBP2-47264, 1 : 50), anti-SELENBP1 (Novus, NBP1-54805, 1 : 50), and anti-CDK1 (Abcam, ab133327, 1 : 50).

Techniques: Expressing, Western Blot, Immunostaining